Encouraging Results of AXON's Tau Vaccine Advance Alzheimer's Therapy
Bioportfolio,
Biotech firm AXON Neuroscience has presented encouraging results from a Phase 1 study with a vaccine designed to target…
Biotech firm AXON Neuroscience has presented encouraging results from a Phase 1 study with a vaccine designed to target…